SOPHiA GENETICS democratizes Data-Driven Medicine to improve health outcomes and economics worldwide
SOPHiA GENETICS is a health tech company democratizing Data-Driven Medicine (DDM) to improve health outcomes and economics worldwide. By unlocking the power of new-generation health data for cancer and rare diseases management, the Universal SOPHiA DDM™ platform allows clinical researchers to act with precision and confidence. The company’s innovative approach and patented machine learning-based algorithms that call variants with 99.9% specificity and sensitivity enable a community of more than 500 institutions to share knowledge. Together, SOPHiA GENETICS and its users are fostering a new era in healthcare. This achievement has earned SOPHiA GENETICS MIT Technology Review’s recognition as a member of its 50 Smartest Companies.
Our website provides more details and we are always open to discuss our extensive offerings.